Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enoxaparin (lovenox) (1 trial)
docetaxel (taxotere) (1 trial)
masitinib (1 trial)
prednisone (meticorten) (1 trial)
Embolism (Phase 4)
Prostatic Neoplasms (Phase 3)
Pulmonary Embolism (Phase 4)
Thromboembolism (Phase 4)
Thrombosis (Phase 4)
Venous Thromboembolism (Phase 4)
Venous Thrombosis (Phase 4)
Trials (2 total)
Trial APIs (4 total)